During infection with an attenuated strain, virus may be recovered from the upper respiratory tract, and there is an increase in the serum of heemagglutination inhibition (HI), neutralization or complement fixation (CF) titres (Zakstel'skaia et al. 1957 , McDonald et al. 1962 , Meiklejohn 1960 . Not all those vaccinated show rises in antibody levels and evidence of virus multiplication in the nasopharynx; also, the final HI antibody levels found are substantially lower than those found in subjects vaccinated subcutaneously with inactivated virus. These viruses spread to other subjects but there is no evidence that they initiate epidemics. If, some weeks after inoculation, volunteers are challenged with the vaccine strain it is found that most of them cannot be reinfected. In large-scale field trials Russian workers have inoculated many hundreds of thousands of subjects, and during epidemics of influenza A and B have observed two-to three-fold reductions in the incidence of influenza after vaccination by comparison with control groups. The selection of control groups and the methods of surveillance in these studies have been criticized, and other Russian workers have seen no protective effect, though in some cases this has been due to the small amounts of active virus in the vaccines used (Deichman et al. 1958 ).
There are some potential disadvantages to the use of these living vaccines: They are more difficult to store and transport than are inactivated vaccines. Russian work suggests that they may cause reactions in children and that they may fail to infect adults at certain times, particularly in the summer, with the result that some recommend two or three administrations of vaccine (Smorodintsev et al. 1961 ). On the other hand, if the strain used can be diluted substantially, the living vaccine should be more economical of virus than inactivated vaccine and might be used on a larger scale in the face of an epidemic. Unpleasant injections are avoided, but intranasal inoculation is probably no easier to perform than subcutaneous injection.
There are still many uncertainties in this subject and further work is needed, particularly in the development of laboratory tests for the detection of significant differences between virulent and avirulent strains, and in the organization of a thoroughly controlled field study of the effectiveness of live influenza virus vaccines. Measles can be regarded as a generalized virus infection with local multiplication in the respiratory tract at two stages. The respiratory tract provides the portal of entry; later more massive involvement of both upper and lower respiratory tracts provides the source from which virus is shed into the environment. Coryza and pharyngitis occur in virtually every case, bronchitis and bronchiolitis are not uncommon and bronchopneumonia is a well-known complication, rarely fatal in this country but still common in some parts of the world. Mortality is high in India, Africa and South America, mainly due to pneumonia. The death rate for measles admissions in one Nigerian hospital was 25%, and the overall case mortality in Nigeria was estimated at about 5 %. In Chile, the measles death-rate has actually increased in recent years, accounting for 2-3 % of all deaths in 1960 and 51 % of all deaths due to communicable diseases. The mortality from measles in this country has fallen steadily since 1918; in 1961 there were 152 deaths in 763,848 cases, two and a half times the deaths from poliovirus infections. If this were not sufficient justification for preventing the disease, one could add the social inconvenience to parents and schools, the considerable debility for two or three weeks especially in children aged 3 and under, and the very real dangers of bacterial complications and encephalitis. Encephalitis has an incidence estimated variously between 1: 400 and 1: 10,000 of all cases of measles and a case mortality of about 10%. Apart from classical post-measles encephalitis, which is probably allergic in type, measles virus may affect the C.N.S. directly: 50 % of otherwise uncomplicated cases of measles show EEG changes at the height of the fever; in 10% the changes last some months and in 3 % persist indefinitely. The group with permanent changes -had a high incidence of behaviour disorders and convulsive tendencies. The suggestion is that during the course of 'natural' measles a normally undetectable degree of brain damage is inflicted by the virus in certain cases.
Before 1954 laboratory studies were limited by the need to use monkeys, the only susceptible experimental animals, and the results were highly variable. It is now known that measles is a common infection amongst captive monkeys, and the irregularity of these early results is thought to be due to the use of a varying proportion of immune animals. Enders & Peebles (1954) described the isolation of measles virus in tissue culture and its distinctive cytopathic effect; they laid the basis for quantitative studies on propagation of the virus, estimation of antibodies and the production of attenuated variants. Milovanovi6 et al. (1957) succeeded in one of many attempts to adapt a strain to chick embryos. This strain, Edmonston, had previously been through more than 50 passages in human tissue cultures. Katz et al. (1958) adapted this strain to tissue cultures of chick embryos and prepared experimental vaccines from them. This strain differed from the original isolate in a number of characters and produced no signs of disease in susceptible monkeys, but solid immunity to subsequent challenge by a monkey-virulent strain. A second vaccine was prepared from a few further passages in chick embryos, and the two (known as Enders vaccine A and B), have been extensively studied in children in the U.S.A. and elsewhere.
When these vaccines were given by the subcutaneous or intramuscular route, almost all children with no demonstrable antibody or history of measles developed antibodies of a level comparable to that found after naturally occurring measles. Most of the children had a short pyrexia about a week after vaccination, and somewhat fewer had a sparse morbilliform rash. Constitutional upsets and respiratory symptoms were slight or absent. In spite of the obvious resembblance to very mild measles susceptible contacts were not infected. Virus could only be recovered infrequently and with difficulty from throat washings or blood. Individuals with circulating antibody from past active infection, or maternally acquired as in very young infants, failed to show any response to vaccine either clinically or serologically.
The vaccine has given high protection against challenge with natural measles during subsequent epidemics. Protection rates of 95 % to 100 % have been observed. The first group of children to be vaccinated still have high levels of antibody three and a half years later.
The controversial aspect of this vaccine is the reaction which occurs in about 70-80 % of vaccinated children. Some regard it as tolerable and a useful guide to the 'take'. About 10% have fairly typical mild measles with five days of illness, another 40 % have two days of illness. The remainder have rash, or fever, or both, or neither, but are not clinically unwell. The same vaccine given to different groups of children or at different seasons of the year has given different rates of reaction; more febrile responses, catarrhal symptoms and respiratory complications occur in the winter seasons. This suggests that part of the reaction may be due to activation of other agents present in the respiratory tract during the winter. In two trials febrile convulsions occurred in about 3 %. However, EEG studies have shown absence of the changes that accompany naturally occurring measles.
Attempts to reduce the vaccination reaction are being made by: (1) Giving a minute dose of gamma-globulin at the same time but in a different site.
(2) Giving one or two injections of a killed measles vaccine first. (3) Seeking further attenuation of the virus by further passage. (4) Giving the vaccine by different routes or in diminished dosage. Clinical and serological responses were the same at all ages between 6 months and 5 years, whether large or small doses of virus were given, the only difference being a prolongation of the incubation period with the smaller doses. The intradermal, oral, conjunctival and nasal routes all had high failure rates, but inhalation of an aerosol seemed to take with high doses of virus and gave slightly lower reaction rates than injected vaccine. Each of the other approaches has its difficulties and disadvantages, and some favour the vaccine as it is, provided it is given at the right season and under supervision. The combination with globulin or killed vaccine would be expensive and administratively complicated; it might suit advanced countries but not those areas where vaccine is most needed. Further attenuation means the development of new strains which will require assessment by carefully designed trials in children; a derivative of Edmonston described by Schwarz (1962) seems a step in the right direction.
To summarize, measles should be prevented because in many parts of the world it is a killer; even in areas of low mortality like this country, measles causes an unjustifiable amount of damage and inconvenience. The parenteral injection of the attenuated Enders vaccine grown in chick embryo tissue culture gives high and probably lasting protection. A variable proportion of children develop fever and a modified measles rash about a week after vaccination; this reaction is regarded as tolerable by some and objectionable by others. Various methods of reducing the reaction are being tried.
Mr S A Keeble (Glaxo Laboratories Ltd, Greenford, Middlesex)
Attenuated Canine Distemper Vaccine
The classical work on canine distemper infection was carried out in the 1920s by Dunkin & Laidlaw (1926) who demonstrated that the cause was a filterable agent. They were able to produce a potent hyperimmune serum which conferred a passive immunity protecting susceptible dogs against challenge, and later they developed an inactivated tissue vaccine which was used in conjunction with fully virulent virus.
Vaccines of this type had many disadvantages in that they were difficult to standardize and depended upon the use of virulent virus to reinforce the otherwise weak immunity. Often this resulted in clinical infections in the insufficiently protected dog.
The ferret was shown to be susceptible to the virus and, by serial passage of virus in the ferret, Green (1939) partially attenuated it for the dog and manufactured what was known as 'distemperoid' vaccine. Haig (1948) succeeded in growing this ferret passage virus on the chorio-allantoic membrane of eggs. After many such passages it was shown to be completely attenuated for the dog and the ferret, but was still capable of stimulating immunity when administered by subcutaneous inoculation. Vaccines prepared from virus at about the 200th egg passage level are used all over the world. In the United States an independently isolated strain was used at lower passage level with equal success. Subsequently the Onderstepoort workers have stated that the 200th passage level virus is not always fully antigenic and they prefer vaccines produced from earlier passes.
Embryonated eggs provide a convenient method of virus titration and antiserum evaluation, since the virus causes distinctive lesions on the chorioallantoic membrane. It is therefore much easier to standardize these than earlier vaccines and the British Veterinary Codex stipulates that vaccines shall be capable of infecting eggs at a dilution of 1/1,000 and, at the same dose, of protecting ferrets against virulent challenge. According to published reports, from 60 to 600 egg infecting doses (EID50) represent one immunizing dose; most commercial vaccines contain from 5,000 to 50,000 EID50 per vaccine dose, depending on the strain of virus used.
The chick embryo vaccine is extremely thermolabile and suspensions in fluid media must be stored at -70°C. For this reason commercial vaccines are freeze-dried in various protecting media. Such preparations show little loss of potency after six months at +40 C, although Piercy (1961) has shown that at +320 C most of the activity is lost in two weeks.
Recently several attenuated vaccines have been prepared from tissue cultures. It is claimed that they are more potent than chick embryo vaccines, possibly because of easier dispersal of the virus particles which in tissue culture vaccines are not bound to protein material; there is also less risk of initiating protein reactions. Marshall et al. (1961) suggest that, with tissue culture vaccine, full immunity to challenge may develop as early as the third day and others have reported similar results with chick embryo vaccine. This early protection is probably due to an interference phenomenon. Serologically one finds that serum antibodies rise steadily for up to two months and then fall. The rate of antibody decline is logarithmic at the rate of 0 5 log every six to seven months (Fig 1, broken line) . Thus, assuming a titre of 1/20 to be the minimum protective titre, the dog will become susceptible about two years distemper. Broken line shows the rate of fall, after the initial peak at three months, in the absence of contact infection. Twelve dogs were maintained in strict isolation for this experiment; the points represent the geometric mean titres.
Unbroken line shows the effect in a group of 30 dogs of contact with live virusfive months after vaccination; a considerable rise is seen in the geometric mean titres. No clinical signs were apparent at any time after vaccination; in practice it has been found advisable to revaccinate about two years later all dogs which, because of conditions of relative isolation are unlikely to have been exposed to street virus.
Re-vaccination with live vaccine in the presence of antibody is thought by some to be oflittle value, but others report that significant boosting can be obtained. Such boosting can certainly occur from contact with virulent street virus and this has previously been important in maintaining the immune status of the vaccinated dog (see Fig 1) . However, as the prevalence of street virus is reduced by vaccination, so the need for re-vaccination rises.
Canine distemper vaccines are some of the safest of all attenuated vaccines. There is rarely any systemic disturbance regardless of whether the vaccine is used in a St Bernard weighing 100 lb or a Pekinese weighing 10 lb. Under controlled experimental conditions it is rare to see even a slight temperature rise, and in practice any postvaccinal disturbances are usually attributable to other concurrent infections. The virus is not excreted and therefore cannot regain virulence by passage. It also appears to be an extremely efficient immunizing agent, protection rates of 95 % or over having been reported when the vaccine is given to fully susceptible puppies. One prerequisite of such success is that the puppy shall be free from maternal antibody at the time of administration, as this will neutralize the vaccine virus and reduce the antigenic stimulation. Such antibodies persist in the puppy for twelve to thirteen weeks, depending on the level of the dam's immunity.
In conclusion, I should like to suggest that the success of this vaccine depends firstly on it being fully attenuated, secondly on its non-excretion, thirdly on the high levels of neutralizing antibody which it produces and finally upon its apparent inability to stimulate other latent infections in the inoculated animal.
Mr L A Hemsley (The Buxted Chicken Co Ltd, Uckfield, Sussex)
Newcastle Disease Vaccine
Live Newcastle disease vaccines may give satisfactory protection to the host, but have the disadvantages of transmitting and precipitating other diseases. Live poultry vaccines are produced in chicken eggs so there is a considerable risk of contamination by any organism which can be egg borne. The most serious disease of broiler chicken is the respiratory disease complex, and this is aggravated by live vaccine viruses. Broiler chicken are killed at 9 to 10 weeks, and respiratory disease usually appears from 7 weeks of age onwards. Pullets being reared for egg production appear to be less susceptible to respiratory disease than broiler chicken, and have several weeks in which to recover before being subjected to the stress of production, so the use of live vaccines is not so undesirable. It is, of course, important that hens producing hatching eggs should not be infected with any vac6ine-borne disease that might be transmitted through the egg to their offspring.
The protection afforded to the host by the different live vaccines has been described in the Report of the Committee on Fowl Pest (1962) . The most widely used vaccine contains the Bi strain, but when chicks under 21 days old are vaccinated the duration of immunity is only three weeks; for substantial immunity one or more doses are required. A single dose given to birds over 4 weeks of age will give protection for four to five months. Some of the other strains are unsuitable for use in birds under 6 weeks of age, as they cause severe morbidity and some mortality.
A considerable objection to live vaccines is that they may spread other diseases. Some possible contaminants cannot readily be detected, such as the fowl paralysis agent, the infectious synovitis agent, and pleuropneumonia-like organisms, of which the latter play an important part in the respiratory disease complex. Hejl & Faber (1959) found that 35 out of 53 different samples of commercial Newcastle disease vaccines were contaminated by bacteria.
A number of workers in the United States have expressed the opinion that the use of live Neweastle disease vaccine results in the aggravation of the respiratory disease complex (Bankowski 1961 , Gill & Stone 1960 , Osteen et al. 1961 ). Dardiri et al. (1961 showed -that a combination of live Newcastle disease vaccine virus and live infectious bronchitis virus resulted in lesions of the 'air sac syndrome', while a combination of killed Newcastle disease vaccine virus and live infectious bronchitis virus appeared harmless. Gross (1961) reported that coliform pericarditis, a characteristic feature of the respiratory disease complex, could be produced by exposing chicks vaccinated two to twenty-two days previously with Bi Newcastle disease virus to aerosols of pathogenic strains of Escherichia coli, but that this could not be done with unvaccinated chicks.
A tissue culture live virus vaccine is available in the United States. The virus is grown in tissues of other than avian origin, which eliminates the possibility of carrying egg-borne infectious agents in the vaccine. The virus is said to be so modified that it does not cause respiratory symptoms, and therefore does not aggravate or complicate other infectious agents that may be present in the respiratory tract. The duration of immunity is seventeen weeks after a single dose, but immunity lasting for two years has been obtained after two doses. This vaccine and killed vaccines have to be given by parenteral injection, whereas the live Bi strain is usually given in the drinking water or dusted over the birds.
The use of live egg-produced vaccines has enabled the poultry industry in a number of countries to grow or be maintained, but it would appear that future progress will depend on the use of killed virus or tissue culture live virus vaccines.
